[Gadolinium-based contrast agents for magnetic resonance imaging]

Radiologia. 2014 Jun:56 Suppl 1:21-8. doi: 10.1016/j.rx.2014.06.005. Epub 2014 Oct 8.
[Article in Spanish]

Abstract

Gadolinium-based contrast agents are increasingly being used in magnetic resonance imaging. These agents can improve the contrast in images and provide information about function and metabolism, increasing both sensitivity and specificity. We describe the gadolinium-based contrast agents that have been approved for clinical use, detailing their main characteristics based on their chemical structure, stability, and safety. In general terms, these compounds are safe. Nevertheless, adverse reactions, the possibility of nephrotoxicity from these compounds, and the possibility of developing nephrogenic systemic fibrosis will be covered in this article. Lastly, the article will discuss the current guidelines, recommendations, and contraindications for their clinical use, including the management of pregnant and breast-feeding patients.

Keywords: Contrastes; Contrasts; Gadolinio; Gadolinium; Magnetic resonance imaging; Resonancia magnética.

MeSH terms

  • Contrast Media* / adverse effects
  • Gadolinium*
  • Humans
  • Kidney Diseases / chemically induced
  • Kidney Diseases / prevention & control
  • Magnetic Resonance Imaging* / methods
  • Nephrogenic Fibrosing Dermopathy / chemically induced
  • Nephrogenic Fibrosing Dermopathy / prevention & control
  • Risk Factors

Substances

  • Contrast Media
  • Gadolinium